Filing Details
- Accession Number:
- 0001179110-12-014183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-17 21:13:52
- Reporting Period:
- 2012-09-13
- Filing Date:
- 2012-09-17
- Accepted Time:
- 2012-09-17 21:13:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1344153 | H Jeffrey Knapp | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-09-13 | 18,750 | $18.84 | 33,702 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-09-13 | 19,663 | $20.00 | 14,039 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-09-17 | 3,750 | $18.84 | 17,789 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-09-17 | 1,584 | $10.99 | 19,373 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-09-17 | 1,015 | $6.23 | 20,388 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-09-17 | 313 | $7.04 | 20,701 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-09-17 | 6,662 | $20.75 | 14,039 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-13 | 18,750 | $0.00 | 18,750 | $18.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-17 | 3,750 | $0.00 | 3,750 | $18.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-17 | 1,584 | $0.00 | 1,584 | $10.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-17 | 1,015 | $0.00 | 1,015 | $6.23 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2012-09-17 | 313 | $0.00 | 313 | $7.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 54,025 | 2016-07-27 | No | 4 | M | Direct | |
| 50,275 | 2016-07-27 | No | 4 | M | Direct | |
| 3,850 | 2019-01-14 | No | 4 | M | Direct | |
| 23,360 | 2020-07-21 | No | 4 | M | Direct | |
| 10,625 | 2021-07-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Fully vested.
- The Shares vest on a monthly basis in equal installments during the 48 month period beginning on January 1, 2009.
- The Shares vest on a monthly basis in equal installments during the 48 month period beginning on July 22, 2010.
- The Shares vest on a monthly basis in equal installments during the 48 month period beginning on July 11, 2011.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.62 to $20.76,inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes(6)to this Form 4.
Billionaire Hedge Funds
